CTT Pharmaceutical Valuation
| CTTH Stock | USD 0.05 0.0001 0.20% |
CTT Pharmaceutical seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of CTT Pharmaceutical from analyzing the firm fundamentals such as current valuation of 18.87 M, and Return On Equity of -4.49 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CTT Pharmaceutical's price fluctuation is out of control at this time. Calculation of the real value of CTT Pharmaceutical is based on 3 months time horizon. Increasing CTT Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CTT Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CTT Pink Sheet. However, CTT Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0489 | Real 0.0407 | Hype 0.05 |
The intrinsic value of CTT Pharmaceutical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CTT Pharmaceutical's stock price.
Estimating the potential upside or downside of CTT Pharmaceutical Holdings helps investors to forecast how CTT pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CTT Pharmaceutical more accurately as focusing exclusively on CTT Pharmaceutical's fundamentals will not take into account other important factors: CTT Pharmaceutical Total Value Analysis
CTT Pharmaceutical Holdings is currently anticipated to have valuation of 18.87 M with market capitalization of 16.17 M, debt of 87.62 K, and cash on hands of 32.12 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CTT Pharmaceutical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
18.87 M | 16.17 M | 87.62 K | 32.12 K |
CTT Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CTT Pharmaceutical has an asset utilization ratio of 21.44 percent. This signifies that the Company is making $0.21 for each dollar of assets. An increasing asset utilization means that CTT Pharmaceutical Holdings is more efficient with each dollar of assets it utilizes for everyday operations.CTT Pharmaceutical Profitability Analysis
The company reported the previous year's revenue of 40 K. Net Loss for the year was (1.38 M) with profit before overhead, payroll, taxes, and interest of 0.About CTT Pharmaceutical Valuation
An absolute valuation paradigm, as applied to CTT Pink Sheet, attempts to find the value of CTT Pharmaceutical based on its fundamental and basic technical indicators. By analyzing CTT Pharmaceutical's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of CTT Pharmaceutical's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of CTT Pharmaceutical. We calculate exposure to CTT Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CTT Pharmaceutical's related companies.CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015. Ctt Pharmaceutical is traded on OTC Exchange in the United States.
8 Steps to conduct CTT Pharmaceutical's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CTT Pharmaceutical's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CTT Pharmaceutical's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CTT Pharmaceutical's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CTT Pharmaceutical's revenue streams: Identify CTT Pharmaceutical's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CTT Pharmaceutical's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CTT Pharmaceutical's growth potential: Evaluate CTT Pharmaceutical's management, business model, and growth potential.
- Determine CTT Pharmaceutical's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CTT Pharmaceutical's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CTT Pharmaceutical Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -4.1 M |
Complementary Tools for CTT Pink Sheet analysis
When running CTT Pharmaceutical's price analysis, check to measure CTT Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CTT Pharmaceutical is operating at the current time. Most of CTT Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of CTT Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CTT Pharmaceutical's price. Additionally, you may evaluate how the addition of CTT Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |